Detalles de la búsqueda
1.
A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients.
J Immunol
; 206(3): 580-587, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33298615
2.
Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients.
J Immunol
; 198(2): 927-936, 2017 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27986910
3.
Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy.
Cancer Immunol Immunother
; 67(12): 1845-1851, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30218171
4.
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study.
Cancer Immunol Immunother
; 66(4): 441-449, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28008452
5.
Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing-Based Comprehensive Tumor Profiling in Liquid Biopsy Samples.
J Mol Diagn
; 26(1): 61-72, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865292
6.
Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.
Vaccines (Basel)
; 12(4)2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675779
7.
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.
Front Immunol
; 14: 1271449, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37920460
8.
Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination-A Retrospective Observation.
Vaccines (Basel)
; 10(11)2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366390
9.
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy.
J Immunother Cancer
; 9(12)2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933966
10.
PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.
Cancer Immunol Res
; 7(11): 1891-1899, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31484656
11.
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
PLoS One
; 14(8): e0221301, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31419253
12.
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.
J Immunother Cancer
; 7(1): 307, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730025
13.
A Simple and Rapid Method for Quality Control of Major Histocompatibility Complex-Peptide Monomers by Flow Cytometry.
Front Immunol
; 8: 96, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28228758
14.
The prognostic impact of specific CD4 T-cell responses is critically dependent on the target antigen in melanoma.
Oncoimmunology
; 4(1): e955683, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26097797
15.
Monocytic myeloid-derived suppressor cells in advanced melanoma patients: Indirect impact on prognosis through inhibition of tumor-specific T-cell responses?
Oncoimmunology
; 3(1): e27845, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24800171
16.
Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells.
Clin Cancer Res
; 20(6): 1601-9, 2014 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24323899
17.
Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
Cancer Immunol Res
; 2(7): 668-78, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24906352
18.
Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma.
Clin Cancer Res
; 20(16): 4390-9, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24938524
19.
Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people.
Age (Dordr)
; 35(4): 1387-99, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22661297
20.
Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis.
J Clin Oncol
; 30(15): 1835-41, 2012 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22529253